cobalt has been researched along with Cancer of Prostate in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (23.68) | 18.7374 |
| 1990's | 4 (10.53) | 18.2507 |
| 2000's | 16 (42.11) | 29.6817 |
| 2010's | 8 (21.05) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Aasbrenn, M; Abd El-Aty, AM; Abdu, A; Abraha, HB; Achour, A; Acquaroni, M; Addeo, P; Agback, P; Agback, T; Al-Alwan, M; Al-Mazrou, A; Al-Mohanna, F; Aliste, M; Almquist, J; Andel, J; Ando, M; Angelov, A; Annuar, MSM; Antwi, K; Arroliga, AC; Arruda, SLM; Asch, SM; Averous, G; Ayaz, S; Ayer, GB; Bachellier, P; Ball, S; Banijamali, AR; Barden, TC; Bartoncini, S; Bedanie, G; Bellò, M; Benić, F; Berhe, GG; Bertiger, G; Beumer, JH; Bhandari, B; Bond, DS; Boules, M; Braüner Christensen, J; Brown-Johnson, C; Burgstaller, S; Cao, L; Capasso, C; Carlevato, R; Carvalho, AE; Ceci, F; Chagas, ATA; Chavan, SG; Chen, AP; Chen, HC; Chen, J; Chen, Q; Chen, Y; Chen, YF; Christ, ER; Chu, CW; Covey, JM; Coyne, GO'; Cristea, MC; Currie, MG; Dahdal, DN; Dai, L; Dang, Z; de Abreu, NL; de Carvalho, KMB; de la Plaza Llamas, R; Deandreis, D; Del Prete, S; Dennis, JA; Deur, J; Díaz Candelas, DA; Divyapriya, G; Djanani, A; Dodig, D; Doki, Y; Doroshow, JH; Dos Santos, RC; Durairaj, N; Dutra, ES; Eguchi, H; Eisterer, W; Ekmann, A; Elakkad, A; Evans, WE; Fan, W; Fang, Z; Faria, HP; Farris, SG; Fenoll, J; Fernandez-Botran, R; Flores, P; Fujita, J; Gan, L; Gandara, DR; Gao, X; Garcia, AA; Garrido, I; Gebru, HA; Gerger, A; Germano, P; Ghamande, S; Ghebeh, H; Giver Jensen, T; Go, A; Goichot, B; Goldwater, M; Gontero, P; Greil, R; Gruenberger, B; Guarneri, A; Guo, Y; Gupta, S; Haxholdt Lunn, T; Hayek, AJ; He, ML; Hellín, P; Hepprich, M; Hernández de Rodas, E; Hill, A; Hndeya, AG; Holdsworth, LM; Hookey, L; Howie, W; Hu, G; Huang, JD; Huang, SY; Hubmann, E; Hwang, SY; Imamura, H; Imperiale, A; Jiang, JQ; Jimenez, JL; Jin, F; Jin, H; Johnson, KL; Joseph, A; Juwara, L; Kalapothakis, E; Karami, H; Karayağiz Muslu, G; Kawabata, R; Kerwin, J; Khan, I; Khin, S; Kidanemariam, HG; Kinders, RJ; Klepov, VV; Koehler, S; Korger, M; Kovačić, S; Koyappayil, A; Kroll, MH; Kuban, J; Kummar, S; Kung, HF; Kurokawa, Y; Laengle, F; Lan, J; Leal, HG; Lee, MH; Lemos, KGE; Li, B; Li, G; Li, H; Li, X; Li, Y; Li, Z; Liebl, W; Lillaz, B; Lin, F; Lin, L; Lin, MCM; Lin, Y; Lin, YP; Lipton, RB; Liu, J; Liu, W; Liu, Z; Lu, J; Lu, LY; Lu, YJ; Ludwig, S; Luo, Y; Ma, L; Ma, W; Machado-Coelho, GLL; Mahmoodi, B; Mahoney, M; Mahvash, A; Mansour, FA; Mao, X; Marinho, CC; Masferrer, JL; Matana Kaštelan, Z; Melendez-Araújo, MS; Méndez-Chacón, E; Miletić, D; Miller, B; Miller, E; Miller, SB; Mo, L; Moazzen, M; Mohammadniaei, M; Montaz-Rosset, MS; Mousavi Khaneghah, A; Mühlethaler, K; Mukhopadhyay, S; Mulugeta, A; Nambi, IM; Navarro, S; Nazmara, S; Neumann, HJ; Newman, EM; Nguyen, HTT; Nicolato, AJPG; Nicolotti, DG; Nieva, JJ; Nilvebrant, J; Nocentini, A; Nugent, K; Nunez-Rodriguez, DL; Nygren, PÅ; Oberli, A; Oderda, M; Odisio, B; Oehler, L; Otludil, B; Overman, M; Özdemir, M; Pace, KA; Palm, H; Parchment, RE; Parise, R; Passera, R; Pavlovic, J; Pecherstorfer, M; Peng, Z; Pérez Coll, C; Petzer, A; Philipp-Abbrederis, K; Pichler, P; Piekarz, RL; Pilati, E; Pimentel, JDSM; Posch, F; Prager, G; Pressel, E; Profy, AT; Qi, P; Qi, Y; Qiu, C; Rajasekhar, B; Ramia, JM; Raynor, HA; Reis, VW; Reubi, JC; Ricardi, U; Riedl, JM; Romano, F; Rong, X; Rubinstein, L; Rumboldt, Z; Sabir, S; Safaeinili, N; Sala, BM; Sandoval Castillo, L; Sau, M; Sbhatu, DB; Schulte, T; Scott, V; Shan, H; Shao, Y; Shariatifar, N; Shaw, JG; She, Y; Shen, B; Shernyukov, A; Sheth, RA; Shi, B; Shi, R; Shum, KT; Silva, JC; Singh, A; Sinha, N; Sirajudeen, AAO; Slaven, J; Sliwa, T; Somme, F; Song, S; Steinberg, SM; Subramaniam, R; Suetta, C; Sui, Y; Sun, B; Sun, C; Sun, H; Sun, Y; Supuran, CT; Surger, M; Svartz, G; Takahashi, T; Takeno, A; Tam, AL; Tang, Z; Tanner, JA; Tannich, E; Taye, MG; Tekle, HT; Thomas, GJ; Tian, Y; Tobin, JV; Todd Milne, G; Tong, X; Une, C; Vela, N; Venkateshwaran, U; Villagrán de Tercero, CI; Wakefield, JD; Wampfler, R; Wan, M; Wang, C; Wang, J; Wang, L; Wang, S; Waser, B; Watt, RM; Wei, B; Wei, L; Weldemichael, MY; Wellmann, IA; Wen, A; Wild, D; Wilthoner, K; Winder, T; Wing, RR; Winget, M; Wöll, E; Wong, KL; Wong, KT; Wu, D; Wu, Q; Wu, Y; Xiang, T; Xiang, Z; Xu, F; Xu, L; Yamasaki, M; Yamashita, K; Yan, H; Yan, Y; Yang, C; Yang, H; Yang, J; Yang, N; Yang, Y; Yau, P; Yu, M; Yuan, Q; Zhan, S; Zhang, B; Zhang, H; Zhang, J; Zhang, N; Zhang, Y; Zhao, X; Zheng, BJ; Zheng, H; Zheng, W; Zhou, H; Zhou, X; Zhu, S; Zimmer, DP; Zionts, D; Zitella, A; Zlott, J; Zolfaghari, K; Zuo, D; Zur Loye, HC; Žuža, I | 1 |
| Arjmand, F; Gómez-Ruiz, S; Siddique, HR; Tabassum, S; Zehra, S | 1 |
| Baldo, TA; Durán, AA; Faria, RC; Freitas, TA; Materón, EM; Melendez, ME; Proença, CA; Wong, A; Zambrano, G | 1 |
| Anderson, J; Kim, Y; Muruganandham, M; Pigge, FC; Schindel, J | 1 |
| Cho, GJ; Choi, WS; Jeong, BY; Kang, SS; Kim, H; Kim, HJ; Kim, YS; Lee, DH; Lee, SH; Park, J; Park, SY; Roh, GS; Shin, E | 1 |
| Choi, EH; Choi, KH; Jung, JS; Malkinski, L; Nam, KC; Park, BJ | 1 |
| Alshaker, H; Arafat, T; Böhler, T; Cooper, C; Kawano, Y; Pchejetski, D; Wang, Q; Winkler, M | 1 |
| Botlagunta, M; Kluth, JB; Krishnamachary, B; Mukadam, S; Raman, V; Vesuna, F; Winnard, PT | 1 |
| Choi, J; Elliott, AM; Frank, SJ; Ibbott, GS; Kudchadker, RJ; Martirosyan, KS; Mourtada, F; Sing, D; Stafford, RJ; Swanson, DA; Tailor, RC | 1 |
| An, Y; Gao, JW; Li, XJ; Lin, YH; Lu, N; Pan, XY; Pan, Y; Tie, L; Yu, HM | 1 |
| Berry, JE; Havens, A; Joseph, J; Jung, Y; Kim, J; McGee, S; Mishra, A; Pienta, KJ; Shiozawa, Y; Taichman, RS; Wang, J | 1 |
| Boehmer, D; Budach, V; Deger, S; Loening, SA; Roigas, J; Türk, I | 1 |
| Abramson, LP; Bergh, AR; Borensztajn, J; Bouck, NP; Cornwell, ML; Crawford, SE; Doll, JA; Lee, C; Pins, MR; Stellmach, VM | 1 |
| Espiritu, V; Richardson, M; Singh, G; Stanisz, J; Van Lieshout, T | 1 |
| Chi, SG; Ha, J; Hwang, JT; Jung, SN; Kang, I; Kim, SS; Lee, HJ; Lee, M | 1 |
| VERMOOTEN, V | 1 |
| RAVINA, A | 1 |
| JAFFE, HL; RUSCHE, CF | 3 |
| BALFOUR, J; GOODMAN, GB | 1 |
| CARLTON, CE; DILLON, JR; DYKHUIZEN, RF; GEORGE, FW | 1 |
| Tucker, RD | 1 |
| Esumi, H; Minchenko, D; Minchenko, O; Ogura, T; Opentanova, I | 1 |
| Arnold, W; Giese, K; Kaufmann, J; Klippel, A; Schwarzer, R; Tondera, D | 1 |
| Ellis, LM; Evans, DB; Gallick, GE; Gray, MJ; Semenza, GL; Watowich, SS; Zhang, J | 1 |
| Cukurovali, A; Erulas, FA; Karatas, F; Ozmen, H; Yalcin, O | 1 |
| Ha, J; Hwang, JT; Kim, EJ; Kim, MJ; Kim, SS; Lee, M; Yun, H | 1 |
| Chen, ZQ; Li, XJ; Lin, YH; Lu, N; Pan, Y; Zhou, H | 1 |
| Bankson, JA; Frank, SJ; Kudchadker, RJ; Li, C; Martirosyan, KS; Stafford, RJ; Swanson, DA | 1 |
| Adams, J; Hazuka, MB; Ibbott, GS; Kinzie, JJ; Stroud, DN | 1 |
| Parida, GR; Park, JB; Paulus, JA; Tucker, RD | 1 |
| Barczak, AK; Coyle, JT; Luthi-Carter, R; Speno, H | 1 |
| Claffey, K; Holland, JF; Kirschenbaum, A; Levine, AC; Liu, XH; Stearns, ME; Yao, S | 1 |
| Hanrahan, C; Simons, JW; van der Poel, H; Zhong, H | 1 |
| Böhmer, D; Budach, V; Deger, S; Loening, SA; Roigas, J; Türk, I | 1 |
| Furnari, S; Mattea, E; Pavone-Macaluso, M; Veroux, G | 1 |
| Kirchheim, D | 1 |
1 review(s) available for cobalt and Cancer of Prostate
| Article | Year |
|---|---|
Use of interstitial temperature self-regulating thermal rods in the treatment of prostate cancer.
Topics: Alloys; Biocompatible Materials; Cobalt; Humans; Hyperthermia, Induced; Male; Palladium; Prostatic Neoplasms; Transurethral Resection of Prostate; Treatment Outcome | 2003 |
3 trial(s) available for cobalt and Cancer of Prostate
| Article | Year |
|---|---|
Topics: 3-Hydroxybutyric Acid; Acetazolamide; Acrylates; Administration, Intravenous; Adolescent; Adult; Aerosols; Afghanistan; Aflatoxin M1; Agaricales; Aged; Aged, 80 and over; Agricultural Irrigation; Air Pollutants; alpha-L-Fucosidase; Amino Acid Sequence; Androgen Antagonists; Animals; Antibodies, Bacterial; Antigens, Bacterial; Antineoplastic Agents; Antioxidants; Apoptosis; Artifacts; Autophagy; B7-H1 Antigen; Bacterial Proteins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Bile; Bioelectric Energy Sources; Biosensing Techniques; Body Mass Index; Brain; Brazil; Breast Neoplasms; Bufo arenarum; Burkholderia; C-Reactive Protein; Cadmium; Carbon Compounds, Inorganic; Carbon-13 Magnetic Resonance Spectroscopy; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Carcinoma, Transitional Cell; Case-Control Studies; CD4-Positive T-Lymphocytes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Characiformes; Child; China; Cities; Cobalt; Colonic Neoplasms; Copper Sulfate; Cross-Sectional Studies; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Deoxycytidine; Diagnosis, Differential; Digestive System; Dihydroxyphenylalanine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Barcoding, Taxonomic; DNA, Bacterial; Dose-Response Relationship, Drug; Down-Regulation; Edetic Acid; Electrochemical Techniques; Electrodes; Embolization, Therapeutic; Embryo, Nonmammalian; Environmental Monitoring; Enzyme-Linked Immunosorbent Assay; Epithelial-Mesenchymal Transition; Fatty Acids; Feces; Female; Follow-Up Studies; Food Contamination; Forkhead Box Protein M1; Fresh Water; Fungicides, Industrial; Gallium Isotopes; Gallium Radioisotopes; Gastrectomy; Gastric Bypass; Gastric Outlet Obstruction; Gastroplasty; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Bacterial; Genetic Markers; Genome, Bacterial; Genome, Mitochondrial; Glioma; Glycogen Synthase Kinase 3 beta; Goats; Gonads; Guatemala; Halomonadaceae; HEK293 Cells; Helicobacter Infections; Helicobacter pylori; Hepacivirus; Histone-Lysine N-Methyltransferase; Hormones; Humans; Hydroxybutyrate Dehydrogenase; Hypersplenism; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Iran; Japan; Lactuca; Laparoscopy; Larva; Ligands; Liver Neoplasms; Lymphocyte Activation; Macrophages; Malaria; Male; Mercury; Metabolic Syndrome; Metals, Heavy; Mice; Middle Aged; Milk, Human; Mitochondria; Models, Molecular; Molecular Structure; Mothers; Multilocus Sequence Typing; Muscles; Mutation; Nanocomposites; Nanotubes, Carbon; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Neuroimaging; Nitriles; Nitrogen Isotopes; Non-alcoholic Fatty Liver Disease; Nuclear Magnetic Resonance, Biomolecular; Obesity; Obesity, Morbid; Oligopeptides; Oxidation-Reduction; Pancreatic Neoplasms; Particle Size; Particulate Matter; Pepsinogen A; Pesticides; Pharmacogenetics; Phosphatidylinositol 3-Kinases; Phospholipids; Phylogeny; Plasmodium ovale; Plasmodium vivax; Platelet Count; Polyhydroxyalkanoates; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postoperative Complications; Pregnancy; Prevalence; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Domains; Proto-Oncogene Proteins c-akt; Proton Magnetic Resonance Spectroscopy; Pseudogenes; PTEN Phosphohydrolase; Pyrazoles; Pyrimidines; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals; Rats, Long-Evans; Rats, Sprague-Dawley; RAW 264.7 Cells; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Receptor, Notch3; Receptors, G-Protein-Coupled; Receptors, Urokinase Plasminogen Activator; Recombinant Proteins; Repressor Proteins; Resveratrol; Retrospective Studies; Risk Assessment; Risk Factors; RNA, Messenger; RNA, Ribosomal, 16S; Salinity; Salvage Therapy; Seasons; Sequence Analysis, DNA; Seroepidemiologic Studies; Signal Transduction; Skin; Snails; Soluble Guanylyl Cyclase; Solutions; Spain; Species Specificity; Spheroids, Cellular; Splenic Artery; Stomach Neoplasms; Streptococcus pneumoniae; Structure-Activity Relationship; Sulfonamides; Sunlight; Surface Properties; Surgical Instruments; Surgical Wound Infection; Survival Rate; Tetrahydrouridine; Thinness; Thrombocytopenia; Tissue Distribution; Titanium; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Turkey; Ubiquinone; Urologic Neoplasms; Viral Envelope Proteins; Wastewater; Water Pollutants, Chemical; Weather; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Young Adult | 2007 |
Interstitial hyperthermia using self-regulating thermoseeds combined with conformal radiation therapy.
Topics: Aged; Cobalt; Combined Modality Therapy; Disease Progression; Humans; Hyperthermia, Induced; Male; Middle Aged; Palladium; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Conformal; Treatment Outcome | 2002 |
Interstitial hyperthermia using thermoseeds in combination with conformal radiotherapy for localized prostate cancer.
Topics: Adenocarcinoma; Aged; Cobalt; Combined Modality Therapy; Drug Implants; Electromagnetic Phenomena; Follow-Up Studies; Hot Temperature; Humans; Hyperthermia, Induced; Male; Middle Aged; Palladium; Prostatic Neoplasms; Radiation Injuries; Radiotherapy, Conformal; Treatment Outcome | 2002 |
34 other study(ies) available for cobalt and Cancer of Prostate
| Article | Year |
|---|---|
Water soluble ionic Co(II), Cu(II) and Zn(II) diimine-glycinate complexes targeted to tRNA: structural description,
Topics: Cell Line, Tumor; Cobalt; Coordination Complexes; Copper; Drug Resistance, Neoplasm; Humans; Imines; Male; Metals, Heavy; Prostatic Neoplasms; RNA, Transfer; Solubility; Water; Zinc | 2020 |
Novel enzyme-free immunomagnetic microfluidic device based on Co
Topics: Antibodies; Antigens, Neoplasm; Biomarkers, Tumor; Cobalt; Electrodes; Graphite; Humans; Immunoassay; Iron; Keratin-19; Lab-On-A-Chip Devices; Limit of Detection; Male; Metal Nanoparticles; Microfluidic Analytical Techniques; Prostatic Neoplasms; Reproducibility of Results; Zinc | 2019 |
Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
Topics: Brachytherapy; Catheters; Cobalt; Copper Sulfate; Feasibility Studies; Female; Fiducial Markers; Fish Oils; Humans; Iothalamate Meglumine; Magnetic Resonance Imaging, Interventional; Male; Phantoms, Imaging; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Sepharose; Sodium Chloride; Titanium; Tomography, X-Ray Computed; Uncertainty; Uterine Cervical Neoplasms; Vitamin E | 2013 |
Hypoxia inducible factor-1α directly regulates nuclear clusterin transcription by interacting with hypoxia response elements in the clusterin promoter.
Topics: Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cell Nucleus; Clusterin; Cobalt; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Oxygen; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Isoforms | 2014 |
Size-Dependent Photodynamic Anticancer Activity of Biocompatible Multifunctional Magnetic Submicron Particles in Prostate Cancer Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cobalt; Contrast Media; Ferric Compounds; Folic Acid; Hematoporphyrins; Humans; Magnetic Fields; Magnetic Resonance Imaging; Male; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms | 2016 |
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Cobalt; Docetaxel; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Everolimus; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice, Inbred BALB C; Mice, Nude; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; RNA Interference; Signal Transduction; Taxoids; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Hypoxia-induced human endonuclease G expression suppresses tumor growth in a xenograft model.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cobalt; Endodeoxyribonucleases; Female; Genetic Therapy; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, SCID; Microscopy, Fluorescence; Neoplasms; Promoter Regions, Genetic; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy.
Topics: Anisotropy; Brachytherapy; Cobalt; Contrast Media; Humans; Image Enhancement; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Phantoms, Imaging; Prostatic Neoplasms; Radiopharmaceuticals | 2011 |
Hypoxia-induced up-regulation of aquaporin-1 protein in prostate cancer cells in a p38-dependent manner.
Topics: Aquaporin 1; Calcium; Cell Hypoxia; Cell Line, Tumor; Cobalt; Humans; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostatic Neoplasms; Protein Kinase C; Transcription, Genetic; Up-Regulation | 2012 |
Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer.
Topics: Antimutagenic Agents; Axl Receptor Tyrosine Kinase; Blotting, Western; Cadherins; Cell Hypoxia; Cell Line, Tumor; Cobalt; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Male; Neoplasm Metastasis; Prostatic Neoplasms; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Signal Transduction; Tissue Array Analysis | 2012 |
Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas.
Topics: Adolescent; Adult; Aged; Androgens; Angiogenesis Inhibitors; Animals; Blood Vessels; Castration; Cobalt; Eye Proteins; Humans; Hyperplasia; Hypoxia; In Situ Nick-End Labeling; Male; Mice; Mice, Knockout; Mice, Nude; Neoplasm Transplantation; Neovascularization, Physiologic; Nerve Growth Factors; Pancreas; Prostate; Prostatic Neoplasms; Proteins; Rats; Serpins; Tumor Cells, Cultured | 2003 |
A hypoxic response induced in MatLyLu cells by cobalt chloride results in an enhanced angiogenic response by the chick chorioallantoic membrane.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Chick Embryo; Chorion; Cobalt; Enzyme-Linked Immunosorbent Assay; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Microscopy, Video; Neovascularization, Pathologic; Prostatic Neoplasms; Rats; Time Factors; Transcription Factors; Tumor Suppressor Protein p53; Up-Regulation; Vascular Endothelial Growth Factor A | 2003 |
AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells.
Topics: AMP-Activated Protein Kinases; Base Sequence; Cell Hypoxia; Cell Line, Tumor; Cobalt; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Activation; Gene Expression; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Monosaccharide Transport Proteins; Multienzyme Complexes; Nuclear Proteins; Prostatic Neoplasms; Protein Serine-Threonine Kinases; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Transcription Factors; Transcription, Genetic; Vascular Endothelial Growth Factor A | 2003 |
Use of radioactive cobalt (Co60) in nylon sutures in treatment of carcinoma of bladder; preliminary report.
Topics: Carcinoma; Cobalt; Cobalt Radioisotopes; Humans; Male; Nylons; Prostatic Neoplasms; Sutures; Urinary Bladder Neoplasms | 1955 |
[Treatment of cancer of the gallbladder and prostate by radioactive cobalt].
Topics: Cobalt; Cobalt Radioisotopes; Gallbladder Neoplasms; Humans; Male; Neoplasms; Prostatic Neoplasms; Radioactivity | 1955 |
Treatment of bladder and prostatic cancer by combined interstitial isotope radiation and the cobalt bomb.
Topics: Bombs; Brachytherapy; Cobalt; Cobalt Radioisotopes; Humans; Isotopes; Male; Prostatic Neoplasms; Radioactivity; Radiotherapy; Urinary Bladder Neoplasms | 1957 |
Treatment of bladder and prostatic cancer by combined interstitial isotope radiation and the cobalt bomb.
Topics: Bombs; Brachytherapy; Chromium; Chromium Radioisotopes; Cobalt; Cobalt Radioisotopes; Humans; Isotopes; Male; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1958 |
Treatment of vesical and prostatic carcinoma with atomic medicine.
Topics: Cobalt; Cobalt Radioisotopes; Humans; Male; Nuclear Medicine; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1959 |
CARCINOMA OF BLADDER: COBALT THERAPY.
Topics: Adenocarcinoma; Adenoviridae Infections; Canada; Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cobalt; Cobalt Isotopes; Humans; Male; Neoplasms; Palliative Care; Prognosis; Prostatic Neoplasms; Radioisotope Teletherapy; Radiotherapy Dosage; Urinary Bladder Neoplasms | 1964 |
COBALT-60 TELECURIETHERAPY IN THE DEFINITIVE TREATMENT OF CARCINOMA OF THE PROSTATE: A PRELIMINARY REPORT.
Topics: Carcinoma; Cobalt; Cobalt Isotopes; Humans; Male; Neoplasms; Pathology; Prostatic Neoplasms; Radioisotope Teletherapy | 1965 |
Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activation.
Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cobalt; Deferoxamine; Enzyme Induction; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glycine; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoenzymes; Male; Phosphofructokinase-2; Prostatic Neoplasms; RNA, Messenger; Transcription Factors; Transcription, Genetic; Transcriptional Activation | 2004 |
REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase.
Topics: Apoptosis; Cell Hypoxia; Cell Line, Tumor; Chromones; Cobalt; Dimethyl Sulfoxide; Gene Expression; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Morpholines; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Prostatic Neoplasms; RNA, Antisense; Signal Transduction; Sirolimus; Transcription Factors; Up-Regulation | 2005 |
HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
Topics: Autoradiography; Cell Line, Tumor; Chromatin Immunoprecipitation; Cobalt; DNA-(Apurinic or Apyrimidinic Site) Lyase; DNA-Binding Proteins; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Female; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Immunoprecipitation; Luciferases; Male; Microscopy, Fluorescence; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Nuclear Proteins; Pancreatic Neoplasms; Phosphorylation; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; RNA, Messenger; Signal Transduction; src-Family Kinases; STAT3 Transcription Factor; Trans-Activators; Transcription Factors; Transcription, Genetic; Vascular Endothelial Growth Factor A | 2005 |
Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer.
Topics: Aged; Aged, 80 and over; Ascorbic Acid; Cobalt; Copper; Humans; Iron; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nickel; Prostatic Neoplasms; Selenium; Trace Elements; Vitamin A; Vitamin E; Zinc | 2006 |
Critical roles of AMP-activated protein kinase in the carcinogenic metal-induced expression of VEGF and HIF-1 proteins in DU145 prostate carcinoma.
Topics: Adenoviridae; AMP-Activated Protein Kinases; Arsenates; Carcinogens; Cell Line, Tumor; Cell Survival; Cobalt; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Humans; Hypoxia-Inducible Factor 1; Male; Metals; Multienzyme Complexes; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Vanadates; Vascular Endothelial Growth Factor A | 2006 |
Oxidative stress mediates CoCl(2)-induced prostate tumour cell adhesion: role of protein kinase C and p38 mitogen-activated protein kinase.
Topics: Cell Adhesion; Cell Hypoxia; Cell Line, Tumor; Cobalt; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Imidazoles; Male; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Protein Kinase C; Pyridines; Pyrrolidines; Reactive Oxygen Species; Thiocarbamates | 2007 |
A novel MRI marker for prostate brachytherapy.
Topics: Acrylates; Animals; Brachytherapy; Cobalt; Contrast Media; Dogs; Glass; Magnetic Resonance Imaging; Magnetics; Male; Nitrates; Phantoms, Imaging; Prostatic Neoplasms | 2008 |
Prostatic thermoluminescent dosimeter analysis in a patient treated with 18 MV X rays through a prosthetic hip.
Topics: Chromium; Cobalt; Hip Prosthesis; Humans; Male; Molybdenum; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, High-Energy; Thermoluminescent Dosimetry | 1993 |
Corrosion analysis of NiCu and PdCo thermal seed alloys used as interstitial hyperthermia implants.
Topics: Alloys; Animals; Biocompatible Materials; Cobalt; Copper; Corrosion; Electrochemistry; Hyperthermia, Induced; Isotonic Solutions; Male; Microscopy, Electron, Scanning; Nickel; Palladium; Prostatic Neoplasms; Prostheses and Implants; Ringer's Solution | 1997 |
Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II.
Topics: Animals; Antigens, Surface; Binding, Competitive; Carboxypeptidases; Chelating Agents; Cloning, Molecular; Cobalt; Coumarins; Dipeptides; Edetic Acid; Folic Acid; Glutamate Carboxypeptidase II; Histamine H1 Antagonists; Humans; Hydrolysis; Isocoumarins; Kinetics; Leucine; Male; Neuropeptides; Pepstatins; Phenanthrolines; Prostatic Neoplasms; Protease Inhibitors; Rats; Serine Proteinase Inhibitors; Substrate Specificity; Synaptic Transmission; Tumor Cells, Cultured | 1998 |
Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
Topics: Androgens; Cell Hypoxia; Cobalt; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Drug Interactions; Endothelial Growth Factors; Enzyme Induction; Humans; Isoenzymes; Lymphokines; Male; Membrane Proteins; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Stimulation, Chemical; Sulfonamides; Tumor Cells, Cultured; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Hypoxia-inducible factor 1alpha and 1beta proteins share common signaling pathways in human prostate cancer cells.
Topics: Blood Proteins; Carcinogens; Carrier Proteins; Cell Hypoxia; Cobalt; Dimerization; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epidermal Growth Factor; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunophilins; Male; Nuclear Proteins; Phosphoinositide-3 Kinase Inhibitors; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; Protein Subunits; Signal Transduction; Tetradecanoylphorbol Acetate; TOR Serine-Threonine Kinases; Transcription Factors; Tumor Cells, Cultured; Up-Regulation | 2001 |
Cancer chemotherapy in urology.
Topics: Adenocarcinoma; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Chlorambucil; Cobalt; Dactinomycin; Dysgerminoma; Female; Fluorouracil; Humans; Kidney Neoplasms; Male; Medroxyprogesterone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Papilloma; Prostatic Neoplasms; Teratoma; Testicular Neoplasms; Testosterone; Thiotepa; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vincristine; Wilms Tumor | 1971 |
[Treatment of prostatic carcinomas: stage 3 and IV].
Topics: Carcinoma; Cobalt; Estrogens; Humans; Male; Middle Aged; Prognosis; Prostatic Neoplasms; Radiotherapy, High-Energy; Statistics as Topic; United States | 1971 |